Top Markets
Coin of the day
Cadrenal Therapeutics, Inc. Common Stock Cadrenal Therapeutics, Inc. Common Stock

Cadrenal Therapeutics, Inc. Common Stock

CVKD
Rangering i aksjer #33959
Cadrenal Therapeutics, Inc. operates as a biopharmaceutical enterprise... Cadrenal Therapeutics, Inc. operates as a biopharmaceutical enterprise primarily engaged in clinical development. The company's core focus is the advancement of Tecarfarin, a novel therapeutic agent that has received orphan drug designation. This treatment is engineered to prevent systemic thromboembolism originating from cardiac issues in patients suffering from both end-stage renal disease and atrial fibrillation. Established in 2022, the firm is headquartered in Ponte Vedra, Florida.
Aksjekurs
$1.83
Sist synkronisert: 2026-08-14
Markedsverdi
$6.53M
Endring (1 dag)
-1.61%
Endring (1 år)
-85.57%
Land
US
Handel Cadrenal Therapeutics, Inc. Common Stock (CVKD)

Kategori

EPS for Cadrenal Therapeutics, Inc. Common Stock (CVKD)
EPS per 2026 TTM: 0
Ifølge de siste økonomiske rapportene og aksjekursen til Cadrenal Therapeutics, Inc. Common Stock er selskapets nåværende EPS (TTM) 0. Ved slutten av 2026 hadde selskapet en EPS på 0, lik EPS-en i 2026 som var 0.
EPS-historikk for Cadrenal Therapeutics, Inc. Common Stock fra 2026 til 2026
EPS ved slutten av hvert år
År EPS Endre
Ikke nok data for de angitte datoene.
EPS for lignende selskaper eller konkurrenter